The purpose of this study was to characterize operative outcomes for ascending aorta and arch replacement on a national scale and to develop risk models for mortality and major morbidity.
Despite the development of improved operative techniques and circulatory adjuncts, existing published data suggest that ascending aortic and arch repairs retain significant morbidity and mortality (1) . However, the best clinical studies suffer important limitations, including singleinstitution reporting, small sample sizes, and operative techniques no longer commonly in use. Thus, the objectives of this study are: 1) to report the characteristics and outcomes of patients undergoing ascending aortic and arch replacement in a large contemporaneous North American cohort; and 2) to determine the predictors of mortality and major morbidity for these patients.
Methods

Data source. The Society of Thoracic Surgeons (STS)
Adult Cardiac Surgery Database (ACSD) currently houses data from Ͼ950 participants, representing Ͼ90% of the cardiac surgery centers in the United States. Clinical sites enter data using uniform definitions. The quality of the data has been rigorously assessed by comparison with independent national and regional datasets (2) . The present study was approved by the Access and Publications Committee of the STS Workforce for National Databases as well as by the Duke University institutional review board. Patient population. The study population consists of all patients with aortic pathology requiring repair of the ascending aorta (with or without root) with or without arch reported to the STS ACSD between 2004 and 2009.
Patients undergoing descending or thoracoabdominal aortic replacement were not included. The STS ACSD first began distinguishing aortic replacement location (ascending, arch, descending, and thoracoabdominal) in 2004, with implementation of case report form version 2.52, and the current analysis was based on this form. Data collection and definitions. Those variables previously identified in the peer-reviewed literature as potential predictors of outcome in aortic surgery were included as candidate variables for the analysis, as well as all variables from existing STS 30-day operative mortality and morbidity risk models (3) . Data regarding maximal aortic diameter, use of circulatory arrest or adjunctive cerebral perfusion, connective tissue disorders, and specifics of intraoperative neuromonitoring were not available for study.
The primary outcome variable was operative mortality, defined as death from any cause either in-hospital or within 30 days of the index thoracic aortic operation. The secondary outcome variable was the composite endpoint of operative mortality and major morbidity, where major morbidity was defined using the standard STS database composite of stroke, renal failure, prolonged ventilation, deep sternal wound infection, and reoperation. Further details regarding STS ACSD data definitions are available online. Statistical analysis. Baseline patient characteristics and outcomes were summarized by percentage distribution for categorical variables and by medians and 25th to 75th percentiles for continuous variables. Missing data were rare (Ͻ0.5% for all variables). Missing values of body mass index were imputed to sex-specific median values. Missing values of ejection fraction were imputed to sex-specific median values for patients with congestive heart failure; otherwise, were imputed to 50%. Missing values of remaining risk factors and various outcomes were defaulted to their most common value.
Logistic regression modeling was used to estimate the risk of the individual outcome as a function of patient variables. Models were created for the overall study cohort in addition to the subset of elective patients. Generalized estimating equations methodology was used to fit the models (4); and C statistics were calculated and compared for full and reduced models. For either mortality or major morbidity and mortality, a reduced model was able to explain approximately 99% of the variation in the predicted log odds as estimated by the full model. Full and reduced models were fit again in the overall population to obtain the risk adjusted odds ratios (OR) for predictors. Patient and Operative Characteristics Nonfatal adverse outcomes included stroke or coma in 6.6% of patients, renal failure in 8.3%, perioperative myocardial infarction in 2.4%, and prolonged ventilation in 27.8%. Similar to mortality, stroke rate was highest for cases involving replacement of the supracoronary ascending aorta and arch (Table 2) . Adverse outcomes were more common after nonelective operation, with the exception of perioperative myocardial infarction which occurred with similar frequency after elective and nonelective operation. Predictive models. 4 ; p ϭ 0.0002). However, the adjusted OR for root involvement was 1.0 (95% CI: 0.9 to 1.1; p ϭ 0.72) in the full model and did not remain in the reduced model. Table 4 displays results of the multivariable model for major morbidity or mortality (c-index 0.78), with results of the predictive model being similar to the operative mortality model. Table 5 displays predictors of operative mortality among patients undergoing elective operation (c-index 0.77). Among elective patients, end-stage renal disease (preoperative dialysis) was the strongest predictor of mortality, with adjusted OR 4.0 (95% CI: 2.6, 6.4; p Ͻ 0.0001). For patients undergoing reoperation (any redo sternotomy), adjusted OR for mortality was 2.3 (95% CI: 1.9 to 2.7; p Ͻ 0.0001). Predictors of major morbidity and mortality among elective patients are presented in Table 6 (c-index 0.71), with results of the predictive model again similar to those of the operative mortality model.
Results
Centers
Discussion
The present study provides a broad overview of the current practice and outcomes for proximal aortic replacement in North America. The 45,894 patients captured in the STS ACSD between 2004 and 2009 represent the largest contemporaneous cohort of proximal aortic replacement reported to date. The elective mortality of 3.4% is excellent; however, results markedly deteriorate for nonelective status, and the overall operative mortality of 8.3% and stroke rate of 6.6% indicate room for continued improvement. The multivariable models predicting mortality and major morbidity confirm the critical prognostic importance of procedure status: adjusted OR 5.9 and 2.0, respectively, for operative death with emergent and urgent operation, versus elective cases. Arch involvement was associated with increased risk of mortality and major morbidity; however, root involvement was not. Adverse outcomes appeared more common after supracoronary ascending (with or without arch) replacement, despite being technically less challenging than root replacement, in both elective and nonelective settings, likely secondary to the older age and greater comorbidities of these patients. Among the subset of elective patients, severe renal dysfunction, reoperation status, severe lung disease, and concomitant procedures are the strongest predictors of operative mortality and major morbidity.
While the morbidity and mortality associated with thoracic aortic repair remain high relative to other surgical procedures, patient outcomes have improved in each of the past 3 decades due in part to advances in operative approaches, perioperative care, and increased surveillance (4-6). Single-institution studies from aortic surgery referral centers Figure 2 Operative Mortality
Operative mortality, defined as death from any cause either in-hospital or within 30 days of the index thoracic aortic operation, categorized by procedure status.
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Proximal Aortic Replacement have reported in-hospital mortality ranging from 3% to 8%, 30-day mortality from 5% to 10%, stroke from 3% to 6%, and renal failure from 2% to 10% (7-9). The findings of the present study indicate comparable results among STS ACSD participating centers.
Although an increasing number of proximal aortic replacement cases were reported to the STS ACSD during each year of study, the median number of cases per participant doing at least 1 case has risen only slightly, with the 2008 average being only 12 cases per participating center. A recent study analyzing the effects of institutional volumes on operative outcomes for aortic root replacement in North America using the STS ACSD found a clear, inverse association between hospital procedure volume and post-operative mortality, which appeared most pronounced among centers performing fewer than 30 to 40 elective aortic root procedures per year (10) . Recent data from 2,218 CABG patients, however, has found that outcomes did not vary significantly based on volume but instead were correlated with compliance with National Quality Forum process measures (11) . This finding suggests an opportunity for further systems analysis aimed at optimizing quality of care for patients requiring proximal aortic replacement by examining the role of volume and other processes of care in thoracic aortic surgery.
The risk models presented herein may assist clinicians in risk stratification and patient counseling when planning proximal aortic replacement. Urgent/emergent procedure status, reoperation, chronic renal failure, and pulmonary disease have each been associated with adverse outcomes in smaller observational studies of ascending and aortic arch repair (1,8,9 ) and are corroborated by the results of the present analysis. Performance of concurrent CABG or mitral valve procedure was shown to increase risk for mortality and major morbidity among the overall study cohort (Tables 3 and 4) as well as the subset of elective patients (Tables 5 and 6 ). In addition, concomitant arch replacement was associated with an increased risk for adverse outcomes in all models, but root replacement was not. For the clinician counseling patients before an elective proximal aortic replacement procedure, the predictive models based on data for Ͼ27,000 elective patients provide a guide to estimating the increased risk of perioperative death and major morbidity in the setting of renal disease, lung disease, heart failure, and other comorbidities. The current STS ACSD study presents a first look at outcomes for repair of acute type A aortic dissection in North America, with 94% of the 9,289 emergent cases due to acute aortic dissection. Mortality in this cohort was 21.5%, which is very similar to the approximately 25% 30-day mortality for patients treated surgically in reports from the International Registry of Acute Aortic Dissection (12) . The current cohort represents the largest report of emergent type A dissection repairs to date and, unfortunately, highlights that results with surgical treatment of this disease appear to have improved little over the past 20 years (13) .
The most common indication for replacement of the ascending aorta and/or arch is thoracic aortic aneurysm (8, 13) . Current American College of Cardiology/American Heart Association/American Association for Thoracic Surgery/STS guidelines recommend evaluation for elective repair in asymptomatic patients with an ascending (Class I recommendation) or arch (Class IIa) diameter of 5.5 cm and prompt evaluation for surgical intervention in patients with symptomatic aneurysms (Class I) (14) . These current joint U.S. society guideline size criteria recommendations are based on previous observations that the risk of a serious adverse event (rupture, dissection, death) exceeds the risk of elective operation when the maximum aortic diameter exceeds 5.5 to 6.0 cm. This recommendation is contingent upon the assumption that the risk of operation is approximately 5% (16) . We show herein that the current elective operative mortality is actually only 3.5% across the U.S. and Canada, suggesting that current diameter thresholds may need to be reconsidered.
To this point, in a 2007 report from the International Registry of Acute Aortic Dissection, nearly 60% of acute type A dissection patients had ascending aortic diameters Յ5.5 cm at the time of dissection, and approximately 40% Abbreviations as in Tables 1 and 3 . (17) . If we assume these dissections result in emergent operations, the mortality for those cases, on the basis of the present report, is 21.5%. With an overall elective mortality of only 3.5% for proximal aortic replacement (adjusted OR: 5.9 for operative mortality with emergent vs. elective cases), the question arises as to whether we are waiting too long to intervene. Given the large denominator of patients with ascending aortic diameters between 4 cm and 5 cm, however, it is likely not feasible to simply recommend lowering diameter thresholds as a means of improving overall outcomes by diminishing the number of urgent/emergent procedures (18) . Rather, a more practical approach would be increased screening and improved medical therapy for patients at risk for aortic aneurysm and/or dissection (6) . Continual broadening of clinical awareness of thoracic aneurysms and dissections and the methods of diagnosis should be expected to reduce the need for urgent or emergent operation and thereby reduce associated procedural morbidity and mortality. Study limitations. The clinical registry studied was observational, and the results of the analyses represent hypothesis generation. Although the data source represents a significant majority of U.S. cardiac surgical centers and includes the most recent reported results, data were limited to those reported through the STS ACSD and did not reliably distinguish underlying aortic pathology necessitating proximal aortic replacement. Further, details of the specific operative procedure performed, for example, proximal arch versus total arch, are limited in the data analyzed. However, given the only modest increase in operative and aortic cross-clamp times observed in cases in which concomitant arch replacement was performed (Table 1) , we would predict that the majority of arch procedures reported herein represent proximal or hemiarch replacement. Data were also lacking regarding details of potentially important variations in aortic replacement technique including aortic diameter, connective tissue disorder diagnosis, degree of hypothermia, cerebral perfusion, and use of neurologic monitoring. Finally, all STS ACSD outcomes data are voluntarily self-reported without external adjudication of adverse events or universal auditing, which opens the possibility of under-reporting event rates.
Selected Predictors of Operative Mortality Among Elective Patients
Conclusions
Proximal aortic replacement is increasingly being performed in North America. Current outcomes for ascending aorta and arch replacement are excellent for elective repair; however, results are much less favorable for patients requiring nonelective procedures. This finding suggests increased screening of at-risk populations as well as lowering aortic diameter thresholds triggering elective intervention could potentially improve outcomes by reducing the fraction of operative procedures performed in nonelective circumstances. The predictive models presented may serve clinicians in developing risk stratification strategies when they counsel patients. 
